Source: BioPortfolio

Intellect Neurosciences: Intellect Neurosciences Inc. ILNS Financial and Strategic SWOT Analysis Review Prices from USD $300

SummaryIntellect Neurosciences Inc. Intellect Neuro formerly GlobePan Resources Inc. is a biopharmaceutical company that discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and other serious neurological diso...

Read full article »
Intellect Neurosciences's Competitors | Intellect Neurosciences's News | Intellect Neurosciences's Financials
Stay up-to-date with the latest news on Intellect Neurosciences
Annual Revenue
$5.0-25M
Employees
25-100
Elliot M. Maza's photo - Chairman & CEO of Intellect Neurosciences

Chairman & CEO

Elliot M. Maza

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Intellect Neurosciences